HIV/AIDS Clinical Trials Unit (CTU) COVID-19 Admin Supplement

项目摘要/摘要 北卡罗来纳大学(UNC)全球艾滋病毒临床试验单位(CTU)有一个很好的 建立了高质量、创新的临床研究的记录，强大的科学领导力 (在NIH艾滋病毒/艾滋病网络内外)，以及获得至关重要的感染和 美国东南部、东南亚和南部非洲的高危人群。出自 我们的临床研究团队遍布两大洲，由经验丰富的人领导。 首席研究员(Joseph Eron MD和Mina Hosseiniour MD)，并将支持所有5个NIH 艾滋病毒临床试验网络：成人治疗战略，应对艾滋病毒和艾滋病毒的战略- 儿科和孕产妇人群的相关感染，艾滋病毒的综合预防 预防艾滋病毒感染的战略、杀微生物剂战略和疫苗战略。《临床》 研究站点(CRS)包括由David Wohl医学博士(成人治疗)领导的Chapel Hill CRS 战略、综合预防、杀微生物剂和疫苗)，由Cornelius领导的Greensboro CRS 由马拉维CRS领导的Van Dam医学博士(成人治疗战略和综合预防) Lameck Chinula MD(全部5个网络)和越南(协议特定站点)，由Viian Go领导。 支持这一领导地位的是一个组织良好的研究团队，由全球专家和网站组成 将致力于执行网络科学议程的合作者。CTU也已经 召集了一个由高级科学家和公共卫生官员组成的不同团队，在我们的 科学和战略咨询小组。CTU政府将一项高度 组织有序的结构，将响应我们在CRS的经验丰富的研究团队 并将提供持续的评价，以确保最佳的性能和效率。CTU是 由最先进的通信和卓越的实验室、药房、质量支持 保证、数据管理和监管支持。凭借其强大的行政框架， 北卡罗来纳大学全球艾滋病毒CTU处于最佳地位，可以提供科学领导和临床 推动NIAID艾滋病毒网络和新兴机构议程领域的试验基础设施 传染性疾病，如SARS-CoV-2大流行。

Project Summary/Abstract The University of North Carolina (UNC) Global HIV Clinical Trials Unit (CTU) has a well established track record of high-quality, innovative clinical research, strong scientific leadership (both in and outside the NIH HIV/AIDS Networks), and access to critically important infected and at-risk populations in the Southeastern US, Southeast Asia and in Southern Africa. Drawn from a diverse team of clinical innvestigators spanning two continents, our is led by experienced principal investigators (Joseph Eron MD and Mina Hosseinipour MD) and will support all 5 NIH HIV Clinical Trials Networks: Adult Therapeutic Strategies, Strategies to Address HIV and HIV- associated Infections in Pediatric and Maternal Populations, Integrated HIV Prevention Strategies, Microbicide Strategies, and Vaccine Strategies to Prevent HIV Infection. The Clinical Research Sites (CRS) include Chapel Hill CRS led by David Wohl MD (Adult Therapeutic Strategies, Integrated Prevention, Microbicide and Vaccine), Greensboro CRS led by Cornelius Van Dam MD PhD (Adult Therapeutic Strategy and Integrated Prevention), Malawi CRS led by Lameck Chinula MD (all 5 Networks) and Vietnam (protocol specific site) led by Vivian Go. Supporting this leadership is a well-organized research team, comprising global experts and site collaborators who will work to execute the network scientific agendas. The CTU has also assembled a diverse group of senior scientists and public health officials to serve on our Scientific and Strategic Advisory Group. The CTU administration incorporates a highly organized structure that will be responsive to our experienced research teams across the CRS and will provide ongoing evaluation to ensure optimal performance and efficiency. The CTU is supported by state-of-the-art communications and outstanding laboratory, pharmacy, quality assurance, data management and regulatory support. With its robust administrative framework, the UNC Global HIV CTU is optimally positioned to provide scientific leadership and clinical trials infrastructure to advance the field of agenda of the NIAID HIV networks and emerging infectious disease such as the SARS-CoV-2 pandemic.